Zhimin Wang: Clinical Trials

1 trial sponsored by Zhimin Wang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Zhimin Wang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Temporal Interference Stimulation in Treatment-Resistant Schizophrenia: An Exploratory Study.
Temporal Interference Stimulation - Treatment-resistant Schizophrenia
Not applicableNot yet recruitingZhimin Wang202026-08-012026-08-19

Conditions studied

Schizophrenia, Treatment-Resistant (1)